The use of bifunctional NOP/mu and NOP receptor selective compounds for the treatment of pain, drug abuse, and psychiatric disorders. [electronic resource]
- Current pharmaceutical design 2013
- 7451-60 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review